Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	vitamin transmembrane transporter activity	SLC19A2 SLC19A3 SLC2A6 SLC52A2	8.34e-05	36	129	4	GO:0090482
Pathway	KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	4.89e-05	88	105	6	M16004
Pathway	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5 NFAT5	7.24e-05	137	105	7	M5669
Pubmed	NullHap--a versatile application to estimate haplotype frequencies from unphased genotypes in the presence of null alleles.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	7.70e-17	8	132	7	18681957
Pubmed	Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.15e-15	10	132	7	12559621
Pubmed	[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	3.15e-15	11	132	7	19664392
Pubmed	Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	7.53e-15	12	132	7	20371502
Pubmed	Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	7.53e-15	12	132	7	19936734
Pubmed	Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	7.53e-15	12	132	7	19181658
Pubmed	KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.63e-14	13	132	7	19934297
Pubmed	Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.63e-14	13	132	7	19120281
Pubmed	[Study on the polymorphism of killer cell immunoglobulin like receptor (KIR) gene with systemic lupus erythematosus of North population in China].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.63e-14	13	132	7	18687225
Pubmed	Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	3.24e-14	14	132	7	19875891
Pubmed	Multiple sclerosis associates with LILRA3 deletion in Spanish patients.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	3.24e-14	14	132	7	19421224
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	3.24e-14	14	132	7	15896204
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	6.06e-14	15	132	7	20082646
Pubmed	Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	6.06e-14	15	132	7	19850842
Pubmed	[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	6.06e-14	15	132	7	20356536
Pubmed	Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	6.06e-14	15	132	7	19926642
Pubmed	Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	6.06e-14	15	132	7	20207982
Pubmed	Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	6.06e-14	15	132	7	19493232
Pubmed	Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	6.06e-14	15	132	7	20643584
Pubmed	KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	6.06e-14	15	132	7	17498266
Pubmed	Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	6.06e-14	15	132	7	19326408
Pubmed	Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.07e-13	16	132	7	19897003
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.07e-13	16	132	7	19000141
Pubmed	Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.07e-13	16	132	7	20670355
Pubmed	Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.07e-13	16	132	7	18668235
Pubmed	Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.07e-13	16	132	7	19309280
Pubmed	[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.07e-13	16	132	7	16403292
Pubmed	Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.07e-13	16	132	7	19527230
Pubmed	Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.07e-13	16	132	7	20652381
Pubmed	Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.07e-13	16	132	7	19279038
Pubmed	No association of KIR genes with Behcet's disease.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.07e-13	16	132	7	17868255
Pubmed	A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.07e-13	16	132	7	18643961
Pubmed	Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.07e-13	16	132	7	20331834
Pubmed	HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.07e-13	16	132	7	20210919
Pubmed	[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.82e-13	17	132	7	19968064
Pubmed	Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.82e-13	17	132	7	20878400
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.82e-13	17	132	7	20650299
Pubmed	The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.82e-13	17	132	7	20173784
Pubmed	The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.82e-13	17	132	7	20173792
Pubmed	Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.82e-13	17	132	7	20483367
Pubmed	[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.82e-13	17	132	7	19218127
Pubmed	KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.82e-13	17	132	7	19169284
Pubmed	Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.82e-13	17	132	7	19450876
Pubmed	Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.82e-13	17	132	7	19761533
Pubmed	Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5	2.22e-13	9	132	6	7749980
Pubmed	Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	2.97e-13	18	132	7	19630074
Pubmed	Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	2.97e-13	18	132	7	20200544
Pubmed	Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	2.97e-13	18	132	7	19046302
Pubmed	Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	2.97e-13	18	132	7	20580654
Pubmed	Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	2.97e-13	18	132	7	20519398
Pubmed	Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	2.97e-13	18	132	7	19846535
Pubmed	KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	4.69e-13	19	132	7	18571006
Pubmed	Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	4.69e-13	19	132	7	18778326
Pubmed	Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	4.69e-13	19	132	7	20600442
Pubmed	Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	4.69e-13	19	132	7	18848853
Pubmed	Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	7.19e-13	20	132	7	20193031
Pubmed	Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1	7.30e-13	5	132	5	18755860
Pubmed	Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1	7.30e-13	5	132	5	16112031
Pubmed	Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.07e-12	21	132	7	19861144
Pubmed	Natural killer cells and immune surveillance.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5	1.21e-12	11	132	6	18830515
Pubmed	Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3).	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.57e-12	22	132	7	20492596
Pubmed	[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].	KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	2.42e-12	12	132	6	20137308
Pubmed	Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis.	KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3	4.36e-12	6	132	5	17882223
Pubmed	[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3	7.81e-12	14	132	6	19489269
Pubmed	Immunogenetic characteristics of patients with autoimmune gastritis.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.41e-11	29	132	7	20082482
Pubmed	Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1	1.52e-11	7	132	5	11169255
Pubmed	Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.	KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	3.19e-11	17	132	6	19032228
Pubmed	Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5	4.77e-11	18	132	6	20210918
Pubmed	Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	5.95e-11	35	132	7	19683555
Pubmed	Alternatively spliced forms of human killer inhibitory receptors.	KIR2DS2 KIR2DL2 KIR2DL3 KIR2DS3 KIR2DS5	9.08e-11	9	132	5	8662091
Pubmed	HLA and KIR frequencies in Sicilian Centenarians.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS1 KIR2DS3 KIR2DS5	9.89e-11	20	132	6	20426625
Pubmed	Investigation of activating and inhibitory killer cell immunoglobulin-like receptors and their putative ligands in type 1 diabetes (T1D).	KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1	1.98e-10	4	132	4	26542066
Pubmed	Diversity of the repertoire of p58 killer cell inhibitory receptors in a single individual.	KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS1	9.88e-10	5	132	4	10424431
Pubmed	In contrast to other stimulatory natural killer cell immunoglobulin-like receptor loci, several KIR2DS5 alleles predominate in African Americans.	KIR2DS2 KIR2DS1 KIR2DS3 KIR2DS5	9.88e-10	5	132	4	19410616
Pubmed	Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS1 KIR2DS5	1.42e-09	14	132	5	18945962
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	SEC16B RAPGEF6 EP400 ESRRA ITSN1 CAMSAP3 ADARB1 EFTUD2 SETD2 SVIL DMWD OGA AKAP1 BAG6 CSTF2T WDR62 SON	6.72e-09	774	132	17	15302935
Pubmed	Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes.	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS5	6.88e-09	7	132	4	14607943
Pubmed	Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors.	KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS3	6.88e-09	7	132	4	9430220
Pubmed	Human diversity in killer cell inhibitory receptor genes.	KIR2DL1 KIR2DL3 KIR2DS1 KIR2DS3	1.37e-08	8	132	4	9430221
Pubmed	Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals.	KIR2DS2 KIR2DL1 KIR2DS1 KIR2DS3	2.46e-08	9	132	4	18340360
Pubmed	Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus.	KIR2DL2 KIR2DS1 KIR2DS3 KIR2DS5	4.09e-08	10	132	4	21206914
Pubmed	Prognostic role of KIR genes and HLA-C after hematopoietic stem cell transplantation in a patient cohort with acute myeloid leukemia from a consanguineous community.	KIR2DS2 KIR2DL1 KIR2DS1	5.34e-08	3	132	3	29549293
Pubmed	Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients.	KIR2DS2 KIR2DL2 KIR2DL3	5.34e-08	3	132	3	30696053
Pubmed	Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation.	KIR2DS1 KIR2DS3 KIR2DS5	5.34e-08	3	132	3	19500138
Pubmed	Associations of killer cell immunoglobulin- like receptor genes with rheumatoid arthritis.	KIR2DS2 KIR2DL2 KIR2DL3	5.34e-08	3	132	3	22960345
Pubmed	[Effect of demethylation treatment on the expression of inhibitory receptor KIR gene in NK-92MI cell line].	KIR2DL1 KIR2DL2 KIR2DL3	5.34e-08	3	132	3	19549382
Pubmed	Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients.	KIR2DS2 KIR2DL2 KIR2DS1	5.34e-08	3	132	3	19877200
Pubmed	Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors.	KIR2DL1 KIR2DL2 KIR2DL3	5.34e-08	3	132	3	15879158
Pubmed	Homozygosity for killer immunoglobin-like receptor haplotype A predicts complete molecular response to treatment with tyrosine kinase inhibitors in chronic myeloid leukemia patients.	KIR2DS2 KIR2DL2 KIR2DS1	5.34e-08	3	132	3	23380384
Pubmed	Imputation of KIR Types from SNP Variation Data.	KIR2DS2 KIR2DL2 KIR2DL3	5.34e-08	3	132	3	26430804
Pubmed	Cutting edge: selective expression of inhibitory or activating killer cell Ig-like receptors in circulating CD4+ T lymphocytes.	KIR2DS2 KIR2DL2 KIR2DL3	5.34e-08	3	132	3	18292496
Pubmed	[Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia].	KIR2DS2 KIR2DL1 KIR2DL3 KIR2DS5	9.58e-08	12	132	4	17490516
Pubmed	B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.	KIR2DL1 KIR2DL2 KIR2DL3	2.13e-07	4	132	3	20056126
Pubmed	KIR/HLA ligand incompatibility in kidney transplantation.	KIR2DS2 KIR2DL2 KIR2DL3	2.13e-07	4	132	3	18091530
Pubmed	Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general.	KIR2DL1 KIR2DL2 KIR2DL3	2.13e-07	4	132	3	25037176
Pubmed	HLA-C and KIR genes in hepatitis C virus infection.	KIR2DL1 KIR2DL2 KIR2DL3	2.13e-07	4	132	3	16571411
Pubmed	Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility.	KIR2DS2 KIR2DL2 KIR2DL3	2.13e-07	4	132	3	16929347
Pubmed	[Analysis of HLA-Cw, KIR2D genetic variations in 2 Chinese populations].	KIR2DL1 KIR2DL2 KIR2DL3	2.13e-07	4	132	3	18543232
Pubmed	[Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].	KIR2DL1 KIR2DL2 KIR2DL3	2.13e-07	4	132	3	18269867
Pubmed	A role for KIR gene variants other than KIR2DS1 in conferring susceptibility to psoriasis.	KIR2DS1 KIR2DS3 KIR2DS5	2.13e-07	4	132	3	16829306
Interaction	KIR2DS3 interactions	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3 KIR2DS5 D2HGDH	2.31e-09	20	130	6	int:KIR2DS3
Interaction	KIR3DP1 interactions	KIR2DS2 KIR2DL1 KIR2DS5	1.04e-06	4	130	3	int:KIR3DP1
Interaction	KIR2DL2 interactions	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DS3	1.13e-06	13	130	4	int:KIR2DL2
Interaction	KIR2DS2 interactions	KIR2DS2 KIR2DL2 KIR2DS1 KIR2DS3 KIR2DS5	3.82e-06	37	130	5	int:KIR2DS2
Interaction	C2CD4B interactions	APC LRP1B PHKB SETD2 SVIL	9.18e-06	44	130	5	int:C2CD4B
Cytoband	19q13.4	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	3.38e-09	79	132	7	19q13.4
GeneFamily	CD molecules\|Killer cell immunoglobulin like receptors	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	1.68e-12	18	89	7	620
GeneFamily	Vestigial like family	VGLL4 VGLL1	1.43e-04	4	89	2	367
GeneFamily	LEM domain containing	LEMD3 LEMD1	4.95e-04	7	89	2	1087
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	ANPEP NT5E KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS5	7.19e-04	394	89	8	471
GeneFamily	Copines	CPNE3 CPNE4	8.43e-04	9	89	2	829
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	MAP1B CAMSAP3 APC WNK1 AKAP1	2.00e-03	181	89	5	694
GeneFamily	Endogenous ligands\|Minor histocompatibility antigens	WNK1 MTHFD1 SON	2.02e-03	51	89	3	870
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZFHX4 TSHZ1	2.41e-03	15	89	2	529
Coexpression	KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE	KIR2DS2 KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	4.78e-09	49	131	7	M40909
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500	APC SALL4 ZCCHC14 ROBO2 ASXL2 NFAT5	1.25e-05	89	122	6	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k2
Drug	D-Au	KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5 VGLL1	2.90e-07	77	130	7	CID000277822
Drug	Metaraminol bitartrate [33402-03-8]; Down 200; 8.6uM; PC3; HT_HG-U133A	CYP3A4 APC ACAD10 LRRK1 THSD1 GPR107 KCNB1 OGA AKAP1	1.86e-06	195	130	9	3669_DN
Drug	Aa1	KIR2DL1 KIR2DL2 KIR2DL3 KIR2DS1 KIR2DS3 KIR2DS5	8.13e-06	83	130	6	CID009549188
Drug	daunorubicin HCl; Up 200; 1uM; MCF7; HT_HG-U133A	ZNF821 TMEM144 HIVEP2 MID2 APC SNRK HIC2 TEX14	1.05e-05	183	130	8	7507_UP
Drug	Harmol hydrochloride monohydrate [40580-83-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A	MID2 CYP3A4 ATAD5 ITSN1 GPR107 SETD2 ALMS1 CDC42EP2	1.61e-05	194	130	8	2900_DN
Drug	Gemfibrozil [25812-30-0]; Up 200; 16uM; MCF7; HT_HG-U133A	TMEM144 HIC2 PFKFB2 TEX14 LRRN3 ALMS1 OGA AKAP1	1.73e-05	196	130	8	2277_UP
Drug	Rifampicin [13292-46-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A	ZNF821 HIC2 TEX14 THSD1 WNK1 ALMS1 AKAP1 NFAT5	1.73e-05	196	130	8	2847_UP
Drug	LY 294002; Up 200; 10uM; HL60; HT_HG-U133A	HIVEP2 APC ADARB1 CEP164 GPR107 NFAT5 SULT4A1 OR52A1	1.80e-05	197	130	8	6198_UP
Drug	Tobramycin [32986-56-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A	GNPTAB PFKFB2 WNK1 ADARB1 ZCCHC14 ZFHX4 DMRT1 DMWD	1.86e-05	198	130	8	2841_UP
Drug	Lynestrenol [52-76-6]; Down 200; 14uM; MCF7; HT_HG-U133A	TMEM144 HIVEP2 CYP3A4 ACAD10 ALMS1 CDC42EP2 OGA SULT4A1	1.86e-05	198	130	8	1537_DN
Drug	Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; PC3; HT_HG-U133A	ATAD5 ESRRA APC WNK1 ADARB1 SVIL CDC42EP2 CSTF2T	1.86e-05	198	130	8	4592_DN
Drug	Dibucaine [85-79-0]; Down 200; 11.6uM; PC3; HG-U133A	HIVEP2 MID2 APC HIC2 AZI2 FAF1 HMG20A OGA	1.93e-05	199	130	8	1889_DN
Disease	level of killer cell immunoglobulin-like receptor 2DS2 in blood serum	KIR2DL1 KIR2DL3	5.24e-05	3	124	2	OBA_2042107
Disease	Torsades de Pointes	CYP3A4 SCN5A	5.24e-05	3	124	2	C0040479
Disease	puberty onset measurement	SEC16B SPEM3 JMJD1C AKAP1 NFAT5	1.90e-04	125	124	5	EFO_0005677
Disease	epididymis-specific alpha-mannosidase measurement	GNPTAB C1S	3.63e-04	7	124	2	EFO_0801577
Disease	arylsulfatase K measurement	ARSK GNPTAB	4.82e-04	8	124	2	EFO_0801395
Disease	diastolic blood pressure, systolic blood pressure	MAP1B CEP164 DHX15 ALMS1 KCNB1 SVIL SCN5A NFAT5 WDR62 TANGO6	5.46e-04	670	124	10	EFO_0006335, EFO_0006336
Disease	diffusing capacity of the lung for carbon monoxide	COL26A1 CFAP43 LRP1B CEP164	7.32e-04	96	124	4	EFO_0009369
Disease	cancer antigen 125 measurement	MUC16 D2HGDH	7.71e-04	10	124	2	EFO_0010603
Disease	sexual dimorphism measurement	SEC16B RAPGEF6 HIVEP2 ATAD5 APC JMJD1C CEP164 FAF1 NFATC2IP ASXL2 PGP CARNS1 GCN1	7.89e-04	1106	124	13	EFO_0021796
Disease	DNA repair protein RAD51 homolog 4 measurement	CYP3A4 TEX14	9.40e-04	11	124	2	EFO_0801531
Disease	N-acetylhistidine measurement	COL26A1 ALMS1	9.40e-04	11	124	2	EFO_0800022
Disease	visceral adipose tissue measurement	SEC16B HIVEP2 MCMDC2 WNK1 HMG20A ROBO2 CPNE4 NFAT5	9.96e-04	481	124	8	EFO_0004765
Disease	cognitive function measurement	SEC16B CCDC146 TEX14 LRP1B JMJD1C DHX15 ZCCHC14 ZNF19 ALMS1 KCNB1 NFATC2IP CPNE3 SLC4A10 ASXL2 OGA	1.02e-03	1434	124	15	EFO_0008354
Disease	motion sickness	LRP1B TSHZ1 CPNE4	1.09e-03	48	124	3	EFO_0006928
Disease	Emery-Dreifuss muscular dystrophy (implicated_via_orthology)	LEMD3 LEMD1	1.12e-03	12	124	2	DOID:11726 (implicated_via_orthology)
Disease	methionine sulfone measurement	CYP3A4 ALMS1	1.12e-03	12	124	2	EFO_0800072
Disease	gallstones	ANPEP JMJD1C UGDH NFAT5	1.14e-03	108	124	4	EFO_0004210
Disease	Prostatic Neoplasms	CYP3A4 ITSN1 APC LRP1B SETD2 TXNDC5 CPNE3 ROBO2 TAF1L	1.20e-03	616	124	9	C0033578
Disease	Malignant neoplasm of prostate	CYP3A4 ITSN1 APC LRP1B SETD2 TXNDC5 CPNE3 ROBO2 TAF1L	1.20e-03	616	124	9	C0376358
Disease	5alpha-pregnan-3beta,20beta-diol monosulfate (1) measurement	CYP3A4 CARNS1	1.33e-03	13	124	2	EFO_0800284
Disease	gallbladder cancer (is_implicated_in)	APC LRP1B	1.33e-03	13	124	2	DOID:3121 (is_implicated_in)
Disease	killer cell immunoglobulin-like receptor 2DS2 measurement	KIR2DL1 KIR2DL3	1.77e-03	15	124	2	EFO_0801746
Disease	anemia (implicated_via_orthology)	APC SLC4A10	1.77e-03	15	124	2	DOID:2355 (implicated_via_orthology)
Disease	language measurement	SEC16B COL26A1 CFAP54 DMRT1	2.50e-03	134	124	4	EFO_0007797
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	SEC16B GARS1 JMJD1C FAF1 NFAT5	2.66e-03	225	124	5	EFO_0008317, EFO_0020947
Disease	hippocampal tail volume	FAF1 SLC4A10	2.86e-03	19	124	2	EFO_0009398
Disease	Profound Mental Retardation	DOCK8 APC SLC4A10 WDR62	2.86e-03	139	124	4	C0020796
Disease	Mental Retardation, Psychosocial	DOCK8 APC SLC4A10 WDR62	2.86e-03	139	124	4	C0025363
Disease	Mental deficiency	DOCK8 APC SLC4A10 WDR62	2.86e-03	139	124	4	C0917816
Disease	Intellectual Disability	HIVEP2 MAP1B DOCK8 APC SETD2 SLC4A10 WDR62	2.88e-03	447	124	7	C3714756
Disease	aspartate aminotransferase to alanine aminotransferase ratio	ANPEP PFKFB2 DHX15 SLC2A6 SLC52A2	3.45e-03	239	124	5	EFO_0010934
Disease	prothrombin time measurement	SLC19A2 JMJD1C	3.49e-03	21	124	2	EFO_0008390

Protein segments in the cluster

Peptide	Gene	Start	Entry
TYTRHPPLLPNGKAL	AZI2	281	Q9H6S1
SGPKRALPPKTLANY	ATAD5	1226	Q96QE3
PLPQNLSGYSLLPLS	ARSK	371	Q6UWY0
RTLPSIGPPSILAYK	ERICH6	236	Q7L0X2
NYSVGSRPLKPLSPL	PFKFB2	481	O60825
SGINYDKPLPPIQVA	EP400	2501	Q96L91
KELNLTNIYAPPLPS	AKAP1	676	Q92667
QSLPKDLIYGPVLPL	CFAP43	216	Q8NDM7
LPLAVFYGPLDAKNP	CFAP54	56	Q96N23
KVKPQPPLSDAYLSG	BAG6	1031	P46379
PGKFYSPLPNDQLLK	BAZ2B	1536	Q9UIF8
YSSKPPLDLAASPGL	CALHM3	306	Q86XJ0
SRGTDGQPLLLPYKP	ALMS1	3256	Q8TCU4
LPQIKLYGPTNFSPI	CPNE3	386	O75131
PATLAFTYKPPGLLR	CARNS1	106	A5YM72
CPGLIYKDPSLPGLE	ACAD10	366	Q6JQN1
YPLPKSDQIGLPDFN	ANPEP	336	P15144
DVYGNDSLIPKPPNS	C7orf31	121	Q8N865
GDIKIIPLYSTLPPQ	DHX15	381	O43143
LASPYLPEGTSKPLS	CAMSAP3	496	Q9P1Y5
APLSPLPKAGSITYR	DMWD	416	Q09019
DPKDQLLLGPTYATP	HADHB	346	P55084
TEPPTESLLLRKPYG	ATP2B3	901	Q16720
LQTPKLYGSPTQIGP	ASXL2	1311	Q76L83
RKPLLPYTPGSDVAG	CRYZ	61	Q08257
PDSYLSAGEIPLPKL	GPR107	251	Q5VW38
YEKPSLSAQPGPTVL	KIR2DS2	126	P43631
TPVKQDLSAPPGYTL	MTCL1	1831	Q9Y4B5
FSPGPILPSTRKLYE	LEMD1	21	Q68G75
QYRGLKAPPAPLAAS	LEMD3	166	Q9Y2U8
PLPVSPSDDKALGYQ	PM20D1	396	Q6GTS8
YLPDAVKGLPLPASL	ASB8	266	Q9H765
CTYLQPLSGPGLPIK	MUC16	13996	Q8WXI7
YEKPSLSAQPGPTVL	KIR2DL2	126	P43627
TAPPIYLNSDLKGPL	LRP1B	4536	Q9NZR2
KSSAVPPGLPVYLDL	MAP1B	2346	P46821
KLTHLPPLPSYGLDL	MCMDC2	101	Q4G0Z9
PANITLKDLPSLYPS	GNPTAB	146	Q3T906
YEKPSLSAQPGPTVL	KIR2DL3	126	P43628
NDSYLLPHLLPSKPG	LRRK1	986	Q38SD2
PLRDSNAPKSPLTGY	HMG20A	96	Q9NP66
LLKSLPLPEYCNPEG	JMJD1C	2281	Q15652
PTPLPFLGNILSYHK	CYP3A4	41	P08684
VPPFLNPLVYGAKTT	OR52A1	286	Q9UKL2
APAPKAYVLGSPALA	PGP	116	A6NDG6
YEKPSLSAQPGPTVL	KIR2DS3	126	Q14952
LKPSTAYAPEGSPIL	FAHD1	46	Q6P587
LAPYLPSVTPGLKAS	GCN1	1651	Q92616
PAKYLSLALDEPPCG	OLIG1	216	Q8TAK6
PPLYTLNKPLLSGIS	ADARB1	611	P78563
PLAAPAGYLTLVPLL	SLC2A6	386	Q9UGQ3
SVYDLLPKELQLPPS	NFAT5	26	O94916
AAIPLPLVKSLLGPY	NAT10	391	Q9H0A0
YEKPSLSAQPGPTVL	KIR2DS5	126	Q14953
LLYSVDSSPPKSLPG	KCNB1	766	Q14721
LPDGPSPLLKNAISL	CDC42EP2	96	O14613
PKSGAPTALLDPRSY	DOCK8	866	Q8NF50
ADILKPVNPYTGLPV	FBXO15	171	Q8NCQ5
LLKPPSQGELPGTEY	FRMPD3	1286	Q5JV73
CLPKLQLYGPTNIAP	CPNE4	401	Q96A23
KLKLQGYQLPSALPP	ITSN1	86	Q15811
TAPPSGLKKYEEPLQ	BCL9L	456	Q86UU0
TALIGEIASPNYPKP	C1S	181	P09871
LLPAFENTKTGIPYP	EDEM1	271	Q92611
DPTPNLKRLSNLPGY	MACC1	506	Q6ZN28
LKSLGPAAPIIDSPY	CSTF2T	101	Q9H0L4
GPKDNPLALQDYTPS	ENAM	881	Q9NRM1
LPKNNSLYVLTPDLP	FAF1	161	Q9UNN5
IPSAPPLYLDSGNKT	CCDC168	5556	Q8NDH2
ALPKVTLPNYDNVPG	CLIP3	271	Q96DZ5
IAPNKPEQGSYLPVL	C4orf54	1206	D6RIA3
PFLTPYLLGPDKNLT	SLC19A2	51	O60779
SEPFLIPYLSGPDKN	SLC19A3	31	Q9BZV2
LPPTPQDISYLAKGK	SALL4	161	Q9UJQ4
LYIKAEPASPDSPKG	ESRRA	11	P11474
YEKPSLSAQPGPTVL	KIR2DL1	126	P43626
QSSPAKEGPLDLYPK	PPRC1	546	Q5VV67
PTVTAGLPLPKAYIQ	MTHFD1	711	P11586
PQGALYSLQPPTDKD	COL26A1	271	Q96A83
LKDLAPGTNPPFLVY	CLIC2	61	O15247
DPKGILNPYKTLPSQ	D2HGDH	506	Q8N465
SPVKNSLRGLPGPYV	DMRT1	251	Q9Y5R6
GSVYEPLKSINLPRP	PHKB	26	Q93100
YEKPSLSAQPGPTVL	KIR2DS1	126	Q14954
LRSPDPGILAYKPGS	PNPLA8	246	Q9NP80
YTGKLLPSDQPAEPN	HIC2	101	Q96JB3
PTPPGYLGISLADLK	RAPGEF6	1506	Q8TEU7
LPPSSYDADQKPGLE	SCRT2	51	Q9NQ03
NAYKLPLAVGPPSLN	TEX14	786	Q8IWB6
FTGPPQLQALKYKDP	SVIL	551	O95425
LQKPTFALGELYPPL	LRRN3	666	Q9H3W5
GPNEKPLYTAEPVTL	OGA	541	O60502
RPPLKKYSFGALSQP	TAF1L	636	Q8IZX4
YNVKSPITGNDLSPP	GARS1	261	P41250
TPGPDPKAYQLLSAR	SLC52A2	261	Q9HAB3
SKKLPDLYGNPPQEL	SCN5A	61	Q14524
LIPDDLSLLKLYPPG	NFATC2IP	136	Q8NCF5
GVDPSPATKYNIPLV	SNRK	271	Q9NRH2
AKGPLASQISGLYLP	NT5E	146	P21589
NAYIPEADATLPLPK	CCDC146	911	Q8IYE0
EADATLPLPKPYGAL	CCDC146	916	Q8IYE0
KLPPNLSPTIEYNDG	APC	2506	P25054
RKYFPSGIPLLSNSP	CEP164	1361	Q9UPV0
LTSLPPNYEISEGKP	CLLU1-AS1	51	Q5K130
SLGKNYKEPEPAPNS	VGLL4	216	Q14135
NSPTLPIYEPGLKEV	UGDH	46	O60701
IPYAPSGEIPKFSLQ	UGDH	471	O60701
EGKQAGYSLPPSPLI	ZFHX4	2656	Q86UP3
PYPDLAGPRKALSQL	ZNF287	56	Q9HBT7
TALGYPVPKPALISL	ZNF19	51	P17023
TKPPLAPGTILYEAE	NIBAN1	61	Q9BZQ8
PDLYKNPGLTQDPGL	SPEM3	696	A0A1B0GUW6
YPQPGLDIIKELTSP	SULT4A1	91	Q9BR01
NSPKLYPEAVLPGFL	TMEM144	256	Q7Z5S9
PKSYTLGQPLRKPDL	THSD1	726	Q9NS62
DYAIGIPSPKLQVPS	SLC4A10	776	Q6U841
LLPLLEKVSNTYPDP	TANGO6	721	Q9C0B7
TISKNYDLSDLPGPP	ROBO2	511	Q9HCK4
YVDPSNPNAGKVLLP	SETD2	2176	Q9BYW2
PALKGAVPLYNPSQV	SEC16B	1021	Q96JE7
PTLYPLASPDLQALL	WDR62	1486	O43379
PGTFRLKYAPPAESL	ZCCHC14	931	Q8WYQ9
TPSKPSGLSLLPDYE	ZNF830	146	Q96NB3
LKNTSGLLYPPEAPE	TRAPPC8	406	Q9Y2L5
PPSAPELKQGLYELS	TXNDC5	181	Q8NBS9
KDIAFSPPVYPAGIL	ZNF821	221	O75541
LSLLPPAYNKPSISL	STRADB	381	Q9C0K7
LLQPLKPSPSSDNLY	WNK1	2181	Q9H4A3
KLLEGLDYLTAPNPP	MID2	391	Q9UJV3
APIPGSPLYTIKAFI	EFTUD2	861	Q15029
PKSGIPLPNESSQYI	HIVEP2	331	P31629
LSELETPGKYSLTPP	VGLL1	231	Q99990
LGSKSPDPYRLAQDP	SON	906	P18583
AAYQLPGTVKPLPAA	TSHZ1	581	Q6ZSZ6
PSPNAPLKRVLAYTG	USP32	626	Q8NFA0